Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02883764 · ClinicalTrials.gov registry record
Cross-sectional Survey of Omega-3 Fatty Acid Blood Levels
A clinical trial of Healthy, sponsored by dsm-firmenich Switzerland.
- Completed
- Registry status
- 834
- Enrollment target
- 1
- Study location
NCT02883764: Completed study of Healthy, sponsored by dsm-firmenich Switzerland.
NCT02883764 is a study of Healthy that has completed, run by dsm-firmenich Switzerland. The registered enrollment target is 834 participants, above the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (29% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02883764, a study of Healthy, has completed, sponsored by dsm-firmenich Switzerland.
- COMPLETED
- Registry status
- 834 participants
- Enrollment target
- 1
- Study location
Study Summary
Employees working at DSM workplaces with an onsite Healthyroads Wellness® biometrics screening program are being offered an opportunity to have their blood fatty acids levels, especially omega-3 fatty acids \[omega-3 index\] measured at no charge. At some locations, participants were offered a single coupon on a 90 day supply of omega-3 capsules. Three months later, all employees at these locations are given a second opportunity to have their blood omega-3 levels \[eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)\] measured. The goals are to: 1) survey dietary EPA+DHA intake and omega-3 blood levels of study population, 2) determine if dietary EPA+DHA intake and omega-3 blood levels change after people have learned their omega-3 index, and 3) determine if differences in omega-3 index concentrations can be detected 3 months later between locations receiving information alone vs information+coupon.
Primary Outcome
Single fingerstick to know blood levels of omega-3s
Conditions Studied
Study Locations (1)
New Jersey
- DSM Nutritional Products - Parsippany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 834 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-12-02 |
What the finished NCT02883764 record still lists
NCT02883764 is an observational study that tracks outcomes without assigning an intervention. The registered 834 participants enrollment target is mid-sized for trials with a published cap, above the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (29% higher).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT02883764 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02883764 about?
NCT02883764 is a clinical study titled "Cross-sectional Survey of Omega-3 Fatty Acid Blood Levels". Employees working at DSM workplaces with an onsite Healthyroads Wellness® biometrics screening program are being offered an opportunity to have their blood fatty acids levels, especially omega-3 fatty acids \[omega-3 index\] measured at no charge. At some locations, participants were offered a singl...
What is the current status of trial NCT02883764?
This trial is currently completed. The enrollment target is 834 participants. The study started on 2016-05. Estimated completion is 2016-12-02.
What conditions does trial NCT02883764 study?
This clinical trial studies the following conditions: Healthy.
Who is sponsoring clinical trial NCT02883764?
This trial is sponsored by dsm-firmenich Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02883764 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02883764's enrollment target sits among peer trials
834 35th of 1090 higher than 1,056 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03670524 · 835 participants · NA
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
- NCT02118467 · 836 participants · Phase 4
Vasoactive Drugs in Intensive Care Unit
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia